Prostate Cancer Trial, Recruiting (NCT05933876)

Prostate Cancer Trial, Recruiting NCT05933876 Sponsor: Institut Investigacio Sanitaria Pere Virgili Condition: Prostate Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05933876 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Prostate Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People whose cancer started in the breast, prostate, lung, or bowel (colorectal), confirmed by a tissue test (biopsy).
People aged 18 or older.
People who have up to five areas where cancer has spread (metastases), located in the bones, lungs, lymph nodes, liver, or brain.
People who are generally well enough to carry out daily activities with little or no limitation, as rated by a standard health scale called the ECOG scale (scores 0 or 1) (confirm with trial site).

Who may not be able to join:

People who have a type of skin cancer that is not melanoma.
People who have previously received radiation treatment to the same body area being considered for this trial.
People who have a condition involving diseases of the blood vessels and connective tissue, known as vascular collagen disease.
People who are pregnant or breastfeeding at the time of joining the trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Meritxell Arenas, PhD., Universitat Rovira i Virgili, Hospital Universitari Sant Joan de Reus

Phone: +34977310300

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05933876

Sponsor: Institut Investigacio Sanitaria Pere Virgili

Phase: Not Applicable

Status: Recruiting

Condition: Prostate Cancer

Trial contact: +34977310300

More information: https://clinicaltrials.gov/study/NCT05933876

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People whose cancer started in the breast, prostate, lung, or bowel (colorectal), confirmed by a tissue test (biopsy).
People aged 18 or older.
People who have up to five areas where cancer has spread (metastases), located in the bones, lungs, lymph nodes, liver, or brain.
People who are generally well enough to carry out daily activities with little or no limitation, as rated by a standard health scale called the ECOG scale (scores 0 or 1) (confirm with trial site).

Who may not be able to join:

People who have a type of skin cancer that is not melanoma.
People who have previously received radiation treatment to the same body area being considered for this trial.
People who have a condition involving diseases of the blood vessels and connective tissue, known as vascular collagen disease.
People who are pregnant or breastfeeding at the time of joining the trial.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Institut Investigacio Sanitaria Pere Virgili

Registry

ClinicalTrials.gov

Start date

1 December 2022

Est. completion

31 December 2037

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Radiological rate; Progression-Free Survival; SABR toxicities

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov